Fundraising Fox
Kurin
San Diego, US · Founded 2015 · Delaware corporation
Find your way into Kurin
Sign up to see every warm intro you have to Kurin
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Kurin team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Kurin manufactures blood culture collection sets with contamination-reducing technology for healthcare providers. The company provides clinical support, data analytics, and outcomes measurement through proprietary platforms.
Founders & leadership
Kurin was founded in 2015 by Bob Rogers, Dave Lloyd, Matt Heindel, and Gino Kang.
DL
GK
Gino KangFounder
BE
Bobby E. RogersExecutive
Board
ER
Eddie RodriguezBoard director
Reported raises · per SEC filings
Form D private placements$2.4M disclosed across 2 rounds · 2016–2017
▶$75KraisedAug 2017 · 1 investors · BiotechnologyRule 506(b)
▶$75KraisedAug 2017 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Bobby E. RogersExecutive Officer, Director
- Eddie RodriguezDirector
- Terry VandewarkerDirector
- Offering amount
- $6M
- Amount sold
- $75K
- Minimum investment
- $50K
- First sale
- Aug 2017
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$2.3MraisedOct 2016 · 28 investors · BiotechnologyRule 506(b)
▶$2.3MraisedOct 2016 · 28 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Eddie RodriguezDirector
- Bobby E. RogersExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $2.3M
- First sale
- Sep 2016
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 5
LabcorpLabCorp provides diagnostic testing services and clinical trial recruitment solutions that connect patient insights to drug development for healthcare providers.
BioMérieuxbioMérieux develops in vitro diagnostic solutions for clinical laboratories and healthcare professionals, covering areas such as antimicrobial stewardship, sepsis, and infectious disease detection. It also provides diagnostics for food safety and quality and pharmaceutical quality control.
MedscapeMedscape is an online platform providing medical news, clinical information, and continuing education resources to physicians and healthcare professionals globally. The platform offers CME courses, drug and disease information, and patient education across multiple specialties.
Magnolia Medical TechnologiesMagnolia Medical develops diagnostic devices to reduce blood culture contamination and false-positive sepsis test results for hospitals and healthcare systems. Its FDA 510(k)-cleared Steripath initial specimen diversion technology is used by clinical care teams to improve diagnostic accuracy for sepsis testing, primarily in the U.S.
OsmosisOsmosis is a US health education platform of short-form medical videos and learning tools, acquired by Elsevier.
Companies working in the same space as Kurin.
Frequently asked questions
- What does Kurin do?
- Kurin manufactures blood culture collection sets with contamination-reducing technology for healthcare providers. The company provides clinical support, data analytics, and outcomes measurement through proprietary platforms.
- Who founded Kurin?
- Kurin was founded by Bob Rogers, Dave Lloyd, Matt Heindel, Gino Kang in 2015.
- How much funding has Kurin raised?
- Kurin has disclosed $2.4M raised across 2 rounds.
- Where is Kurin headquartered?
- Kurin is headquartered in San Diego, US.